Demographic correlates of body size changes in children undergoing treatment for acute lymphoblastic leukemia

Jacques Baillargeon, Anne Marie Langevin, Margaret Lewis, Jaime Estrada, James J. Grady, Judith Mullins, Aaron Pitney, Brad H. Pollock

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Introduction. While it is known that leukemia therapy is associated with obesity in survivorship, limited information is available on its time-related pattern of development and its variation across patient subgroups. The goal of the present study was to examine demographic correlates of body mass index (BMI) changes over time from diagnosis through chemotherapy for children with B-precursor acute lymphoblastic leukemia (ALL). Methods. The study cohort consisted of 307 pediatric patients diagnosed with ALL who were treated at four South Texas pediatric oncology centers between 1990 and 2002. To minimize treatment-related variability, we excluded patients who received cranial irradiation as part of their treatment. Variation in age- and gender-standardized BMI z-scores according to age at diagnosis, gender, and ethnicity were assessed. Results. The overall study cohort exhibited an increase in age- and gender-adjusted BMI z-scores for the first 24 months of chemotherapy followed by a slight decrease in BMI at 30 months (end of therapy). A repeated measures analysis indicated a statistically significant difference in the time-related pattern of BMI changes for age at diagnosis (P = 0.001) but no significant effect for gender (P = 0.32) or Hispanic versus non-Hispanic ethnicity (P = 0.89). Discussion. In our cohort of ALL patients, BMI was elevated at diagnosis (mean standardized BMI z-score = 0.22, standard deviation = 1.4) then increased and remained elevated for the entire duration of chemotherapy. Children who were 2-9 years of age at diagnosis began therapy with a substantially lower BMI and remained lower over the course of chemotherapy than patients aged 10-18 years at diagnosis. It will be important for future investigations to explore the biological and behavioral factors that may underlie such differential patterns of BMI change over time.

Original languageEnglish (US)
Pages (from-to)793-796
Number of pages4
JournalPediatric Blood and Cancer
Volume49
Issue number6
DOIs
StatePublished - Nov 2007
Externally publishedYes

Fingerprint

Body Size
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Body Mass Index
Demography
Drug Therapy
Therapeutics
Cohort Studies
Pediatrics
Cranial Irradiation
Biological Factors
Hispanic Americans
Leukemia
Survival Rate
Obesity

Keywords

  • Acute lymphoblastic leukemia
  • Body mass index
  • Cancer risk
  • Hispanic
  • Obesity

ASJC Scopus subject areas

  • Cancer Research
  • Pediatrics, Perinatology, and Child Health
  • Hematology

Cite this

Demographic correlates of body size changes in children undergoing treatment for acute lymphoblastic leukemia. / Baillargeon, Jacques; Langevin, Anne Marie; Lewis, Margaret; Estrada, Jaime; Grady, James J.; Mullins, Judith; Pitney, Aaron; Pollock, Brad H.

In: Pediatric Blood and Cancer, Vol. 49, No. 6, 11.2007, p. 793-796.

Research output: Contribution to journalArticle

Baillargeon, J, Langevin, AM, Lewis, M, Estrada, J, Grady, JJ, Mullins, J, Pitney, A & Pollock, BH 2007, 'Demographic correlates of body size changes in children undergoing treatment for acute lymphoblastic leukemia', Pediatric Blood and Cancer, vol. 49, no. 6, pp. 793-796. https://doi.org/10.1002/pbc.21063
Baillargeon, Jacques ; Langevin, Anne Marie ; Lewis, Margaret ; Estrada, Jaime ; Grady, James J. ; Mullins, Judith ; Pitney, Aaron ; Pollock, Brad H. / Demographic correlates of body size changes in children undergoing treatment for acute lymphoblastic leukemia. In: Pediatric Blood and Cancer. 2007 ; Vol. 49, No. 6. pp. 793-796.
@article{b91f441725614ff18b7d904c70611dcd,
title = "Demographic correlates of body size changes in children undergoing treatment for acute lymphoblastic leukemia",
abstract = "Introduction. While it is known that leukemia therapy is associated with obesity in survivorship, limited information is available on its time-related pattern of development and its variation across patient subgroups. The goal of the present study was to examine demographic correlates of body mass index (BMI) changes over time from diagnosis through chemotherapy for children with B-precursor acute lymphoblastic leukemia (ALL). Methods. The study cohort consisted of 307 pediatric patients diagnosed with ALL who were treated at four South Texas pediatric oncology centers between 1990 and 2002. To minimize treatment-related variability, we excluded patients who received cranial irradiation as part of their treatment. Variation in age- and gender-standardized BMI z-scores according to age at diagnosis, gender, and ethnicity were assessed. Results. The overall study cohort exhibited an increase in age- and gender-adjusted BMI z-scores for the first 24 months of chemotherapy followed by a slight decrease in BMI at 30 months (end of therapy). A repeated measures analysis indicated a statistically significant difference in the time-related pattern of BMI changes for age at diagnosis (P = 0.001) but no significant effect for gender (P = 0.32) or Hispanic versus non-Hispanic ethnicity (P = 0.89). Discussion. In our cohort of ALL patients, BMI was elevated at diagnosis (mean standardized BMI z-score = 0.22, standard deviation = 1.4) then increased and remained elevated for the entire duration of chemotherapy. Children who were 2-9 years of age at diagnosis began therapy with a substantially lower BMI and remained lower over the course of chemotherapy than patients aged 10-18 years at diagnosis. It will be important for future investigations to explore the biological and behavioral factors that may underlie such differential patterns of BMI change over time.",
keywords = "Acute lymphoblastic leukemia, Body mass index, Cancer risk, Hispanic, Obesity",
author = "Jacques Baillargeon and Langevin, {Anne Marie} and Margaret Lewis and Jaime Estrada and Grady, {James J.} and Judith Mullins and Aaron Pitney and Pollock, {Brad H.}",
year = "2007",
month = "11",
doi = "10.1002/pbc.21063",
language = "English (US)",
volume = "49",
pages = "793--796",
journal = "Pediatric Blood and Cancer",
issn = "1545-5009",
publisher = "Wiley-Liss Inc.",
number = "6",

}

TY - JOUR

T1 - Demographic correlates of body size changes in children undergoing treatment for acute lymphoblastic leukemia

AU - Baillargeon, Jacques

AU - Langevin, Anne Marie

AU - Lewis, Margaret

AU - Estrada, Jaime

AU - Grady, James J.

AU - Mullins, Judith

AU - Pitney, Aaron

AU - Pollock, Brad H.

PY - 2007/11

Y1 - 2007/11

N2 - Introduction. While it is known that leukemia therapy is associated with obesity in survivorship, limited information is available on its time-related pattern of development and its variation across patient subgroups. The goal of the present study was to examine demographic correlates of body mass index (BMI) changes over time from diagnosis through chemotherapy for children with B-precursor acute lymphoblastic leukemia (ALL). Methods. The study cohort consisted of 307 pediatric patients diagnosed with ALL who were treated at four South Texas pediatric oncology centers between 1990 and 2002. To minimize treatment-related variability, we excluded patients who received cranial irradiation as part of their treatment. Variation in age- and gender-standardized BMI z-scores according to age at diagnosis, gender, and ethnicity were assessed. Results. The overall study cohort exhibited an increase in age- and gender-adjusted BMI z-scores for the first 24 months of chemotherapy followed by a slight decrease in BMI at 30 months (end of therapy). A repeated measures analysis indicated a statistically significant difference in the time-related pattern of BMI changes for age at diagnosis (P = 0.001) but no significant effect for gender (P = 0.32) or Hispanic versus non-Hispanic ethnicity (P = 0.89). Discussion. In our cohort of ALL patients, BMI was elevated at diagnosis (mean standardized BMI z-score = 0.22, standard deviation = 1.4) then increased and remained elevated for the entire duration of chemotherapy. Children who were 2-9 years of age at diagnosis began therapy with a substantially lower BMI and remained lower over the course of chemotherapy than patients aged 10-18 years at diagnosis. It will be important for future investigations to explore the biological and behavioral factors that may underlie such differential patterns of BMI change over time.

AB - Introduction. While it is known that leukemia therapy is associated with obesity in survivorship, limited information is available on its time-related pattern of development and its variation across patient subgroups. The goal of the present study was to examine demographic correlates of body mass index (BMI) changes over time from diagnosis through chemotherapy for children with B-precursor acute lymphoblastic leukemia (ALL). Methods. The study cohort consisted of 307 pediatric patients diagnosed with ALL who were treated at four South Texas pediatric oncology centers between 1990 and 2002. To minimize treatment-related variability, we excluded patients who received cranial irradiation as part of their treatment. Variation in age- and gender-standardized BMI z-scores according to age at diagnosis, gender, and ethnicity were assessed. Results. The overall study cohort exhibited an increase in age- and gender-adjusted BMI z-scores for the first 24 months of chemotherapy followed by a slight decrease in BMI at 30 months (end of therapy). A repeated measures analysis indicated a statistically significant difference in the time-related pattern of BMI changes for age at diagnosis (P = 0.001) but no significant effect for gender (P = 0.32) or Hispanic versus non-Hispanic ethnicity (P = 0.89). Discussion. In our cohort of ALL patients, BMI was elevated at diagnosis (mean standardized BMI z-score = 0.22, standard deviation = 1.4) then increased and remained elevated for the entire duration of chemotherapy. Children who were 2-9 years of age at diagnosis began therapy with a substantially lower BMI and remained lower over the course of chemotherapy than patients aged 10-18 years at diagnosis. It will be important for future investigations to explore the biological and behavioral factors that may underlie such differential patterns of BMI change over time.

KW - Acute lymphoblastic leukemia

KW - Body mass index

KW - Cancer risk

KW - Hispanic

KW - Obesity

UR - http://www.scopus.com/inward/record.url?scp=34948875729&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34948875729&partnerID=8YFLogxK

U2 - 10.1002/pbc.21063

DO - 10.1002/pbc.21063

M3 - Article

C2 - 17066457

AN - SCOPUS:34948875729

VL - 49

SP - 793

EP - 796

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

SN - 1545-5009

IS - 6

ER -